Musculoskeletal Interventional Radiology: What Every Doctor Should Know – Dr Rajesh Botchu

Interventional radiology (IR) is a cornerstone of modern medicine, touching upon virtually every medical and surgical speciality. It plays a key role in the diagnosis and management of conditions across the breadth of clinical medicine.

Within this wider field, musculoskeletal intervention
utilises image-guided techniques to perform minimally invasive procedures diagnosing
and treating a range of conditions such as tumours, rheumatological conditions,
trauma, degenerative disease, and more.

There are numerous procedures, this
article will provide a taste of the most pertinent procedures to illustrate how
musculoskeletal IR can contribute to patient care across a range of
applications.

The overarching principle of most musculoskeletal IR
procedures is to use imaging to guide a needle to a given area. This can be
done for diagnosis, most commonly with percutaneous imaging-guided biopsy (IGB)
where a needle is introduced through the skin into a lesion under ultrasound or
CT (Computed Tomography) guidance, thereby obtaining tissue samples from
suspicious bone or soft tissue lesions.

Alternatives are either a non-guided
biopsy (suitable only for superficial lesions) or open surgical biopsies (which
are far more invasive). Percutaneous IGB is used mainly for tumours, but also
for infections and inflammatory conditions. Accurate tissue diagnosis is
essential for guiding further management, including surgery or oncologic
treatment.

Therapeutic uses employ the same principles. For
example, image-guided injections of corticosteroids, local anaesthetics,
hyaluronic acid, biologics, and blood products amongst others help pain relief
and inflammation control in chronic conditions like osteoarthritis, tendinitis,
or bursitis.

To do so, the injection is directed towards joints
(intra-articular), tendons, or soft tissue spaces. Ultrasound, fluoroscopy, and
CT are all methods which can be used to guide the needle to the correct site
with each modality having its own strengths.

Although procedures can and are
also performed without imaging by using landmark techniques, deeper sites of
injection or those near vulnerable structures (e.g. nerves and vessels)
necessitate imaging to ensure safe and accurate delivery.

Other curative treatments include the destruction of
tumours (ablation) using needle tips which generate ice balls (cryotherapy) or
heat (radiofrequency ablation).

Symptomatic relief can also provide great
patient benefit by enabling mobilisation, such as introducing cement into
spinal fractures via a needle (vertebroplasty) or blocking pain sensation from
nerves (nerve block).

These are only some examples of the wide range of
procedures seen in musculoskeletal IR. Almost every clinician will encounter
patients who benefit from such procedures and will benefit from an awareness of
the basic principles of using imaging to perform minimally-invasive procedures
to facilitate treatment and diagnosis across a range of conditions.

Image showing CT guided bone biopsy of tumour

Image showing CT guided bone biopsy of tumour

 

Images showing radiofrequency ablation of osteoid osteoma of tibia

Images showing radiofrequency ablation of osteoid osteoma of tibia

 

Images showing radiofrequency ablation of osteoid osteoma of cervical spine

Images showing radiofrequency ablation of osteoid osteoma of cervical spine

 

Images showing cryotherapy of fibromatosis

Images showing cryotherapy of fibromatosis

 

Images showing three level vertebroplasty for osteoporotic fractures

Images showing three level vertebroplasty for osteoporotic fractures

 

Image showing sacroplasty for osteoporotic fractures

Image showing sacroplasty for osteoporotic fractures

 

Image showing cementoplasty for spinal metastasis

Image showing cementoplasty for spinal metastasis

 Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article

Powered by WPeMatico

New Medical Colleges, Seat Increase Decisions: NMC deadline to institutes to notify on Possible Communication Gaps

New Delhi: The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has asked the medical institutes, that had applied to set up new medical colleges, start new PG medical courses, increase the intake of MBBS seats or PG medical seats, to inform about any possible communication gap regarding the decision taken by the Commission.

Medical Colleges have been asked to bring any possible communication gap to the Commission latest by 29.10.2024 through the email addressed to the Director of MARB at the email ID: ds-marb@nmcindia.gov.in. 

The institutes may also send telephonic messages/conversations to the Medical Assessment and Rating Board of NMC on some specific numbers, NMC mentioned in the notice dated 25.10.2024.

“Attention is invited to the Medical Colleges/Institutions concerned towards the applications invited by the Medical Assessment and Rating Boards (MARB), NMC for the A. Y. 2024-25 for Establishment of New Medical Colleges & increase intake of MBBS seats and start of new PG Courses & increase intake of seats in existing PG Courses,” NMC mentioned in the notice.

“The action on these applications has been taken by MARB and the decisions have already been communicated to the Medical Colleges/Institutions concerned through email and public notices long back. However, if there is any communication gap in this regard in respect of any Colleges, the Medical College/Institution concerned may bring it to the notice of MARB, NMC latest by 29.10.2024 through email addressed to the Director, MARB on the below mentioned email ID: ds-marb@nmcindia.gov.in,” it further added.

NMC added that the College/Institute may also bring it to the notice of MARB, NMC through telephonic message/conversation on the mentioned numbers on 28.10.2024 (Monday) and 29.10.2024 (Tuesday) from 10:30 AM to 04:00 PM:

Referring to the MARB’s notice, NMC Secretary Prof B Srinivas wrote to the principal/dean of all medical colleges on 28.10.2024 and mentioned, “Reference is cited to Public Notice no. N-19011/12/2024-Assessment Cell/MARB dated 25-10-2024 issued by the Medical Assessment and Rating Board (MARB) on the subject mentioned above enclosed herewith. All concerned stakeholders are requested to kindly take note of the same.”

Earlier, the Medical Assessment and Rating Board of NMC had granted permission for MBBS admission at 44 new medical colleges and allowed an increase of MBBS seats in altogether 19 existing medical colleges for the academic year 2024-25.

To view the NMC notice, click on the link below:

https://medicaldialogues.in/pdf_upload/nmc-notice-dated-25102024-258602.pdf

Also Read: NMC Approval to 44 new medical colleges, MBBS seats intake increase at 19 institutes

Powered by WPeMatico

CDSCO declares 4 formulations as spurious including PAN D, SHELCAL 500

New Delhi: The Central Drug Standard Control Organisation (CDSCO) has issued a list of drugs, medical devices, vaccines, and cosmetics for the month of September 2024, wherein, the apex drug regulatory body has declared 4 formulations as spurious.

The list includes Tamsulosin and Dutasteride Tablets (Urimax- D), Calcium and Vitamin D3 Tablets I.P (SHELCAL 500), Pantoprazole Gastro-Resistant and Domperidone Prolonged- Release Capsules I.P. (PAN-D), Nandrolone Decanoate Injection IP 25mg/ml (Deca- Durabolin 25 Inj.).

The actual manufacturers (as per label claim) have claimed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subject to outcome of investigation.

As part of the continuous regulatory surveillance, drugs samples are picked from sales/distribution point, analyzed and list of spurious drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the spurious drugs list is to make stakeholders aware about the spurious drug batches identified in the market.

Also Read: CDSCO declares 5 formulations as spurious: Details

List of Drugs, Medical Devices, Vaccine and Cosmetics declared as Spurious for the Month of September – 2024

S.No

Name of Drugs/medical device/cosmetics

Batch No.

Date of Manufacture

Date of Expiry

Manufactured By

Reason for failure

Drawn By

Firm reply

1.

Tamsulosin and Dutasteride Tablets (Urimax- D)

GH30334

May-23

Apr-25

Under Investigation

Description, Identification and Assay

Drugs Inspector, Odisha

The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subject to outcome of investigation.

2.

Calcium and Vitamin D3 Tablets I.P (SHELCAL 500)

GDXD0581

Aug/202 3

July/202 5

Under Investigation

Identification, Dissolution, Assay and Description.

Drugs Inspector, EZ, Kolkata

The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subject to outcome of investigation.

3.

Pantoprazole Gastro-Resistant and Domperidone Prolonged- Release Capsules I.P. (PAN-D)

23443507

Sep-2023

Aug- 2025

Under Investigation

Assay of both Pantoprazole and Domeperidone

Drugs Inspector, Bihar

The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subject to outcome of investigation.

4.

Nandrolone Decanoate Injection IP 25mg/ml (Deca- Durabolin 25 Inj.)

G202620

10/2022

09/2026

Under Investigation

Identification

Drugs Inspector, NZ,

Ghaziabad

The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. The product is purported to be spurious, however, the same is subject to outcome of investigation.

A drug shall be deemed to be spurious;
a. If it is manufactured under a name which belongs to another drug; or b. if it is an imitation of, or is a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or c. If the label or container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or d. If it has been substituted wholly or in part by another drug or substance; or e. If it purports to be the product of a manufacturer of whom it is not truly a product. (The term “Spurious Drug” has been defined under Section 17-B of the Drugs and Cosmetics Act, 1940)

For more details, check out the full story on the link mentioned below:

https://medicaldialogues.in/pdf_upload/list-of-spurious-drugs-for-the-month-of-sept-2024-258538.pdf

Powered by WPeMatico

Kerala Medical Council plans to create directory of doctors

Amid the National Medical Commission’s directions to the doctors to register themselves on the National Medical Register (NMR), the State Medical Council in Kerala is reportedly planning to create a directory of modern medicine/ allopathy practitioners mentioning their names, registration numbers, qualifications, and additional qualifications.
KSMC is taking these steps to distinguish between “fake” doctors and qualified doctors practising without registering themselves with the Council of Modern Medicine of the Council.
For more information, click on the link below:

Powered by WPeMatico

Madras HC grants relief to MBBS aspirant who mistakenly chose BDS course during counselling

The Madras High Court recently granted relief to a student, who mistakenly chose the BDS course despite being allotted the MBBS course in the first round of counselling.
Disagreeing with the State’s highly technical contention to give capital punishment to the student for a genuine mistake, the HC Division Bench of Justice R Subramaniam and Justice Sunder Mohan upheld the Single-bench order granting relief to the concerned student.

For more information, click on the link below:

Powered by WPeMatico

Anxious about the election? Psychologists explain how to cope

Obsessively scrolling through the latest polling averages? Overwhelmed by campaign ads about threats to democracy? Paralyzed with nerves about Election Day and what comes next?

Powered by WPeMatico

For type 2 diabetes, focusing on when you eat, not what, can help control blood sugar

Type 2 diabetes affects 1.2 million Australians and accounts for 85-90% of all diabetes cases. This chronic condition is characterized by high blood glucose (sugar) levels, which carry serious health risks. Complications include heart disease, kidney failure and vision problems.

Powered by WPeMatico

MAiD and marginalized people: Coroner’s reports shed light on assisted death in Ontario

Earlier this month, the Office of the Chief Coroner for Ontario released news reports highlighting some of the reasons Canadians have chosen medical assistance in dying (MAiD, which in Canada involves euthanasia—meaning medically-administered injection rather than self-administered—over 99.9% of the time).

Powered by WPeMatico

Playing in mud and dirt can boost your child’s immune system—here’s how

With the popularity of CleanTok on social media, we’re constantly being reminded about how dirty everything around us is. But while you might feel you should disinfect every surface in your home or send your child off to school with antibacterial gels so their hands stay clean, science actually shows us that being exposed to a bit of dirt can be good for kids’ health.

Powered by WPeMatico

Researchers identify deletions in long noncoding RNA that lead to severe neurodevelopmental disorder

Broad Institute-led research has revealed that deletions in the CHASERR gene cause a distinct neurodevelopmental disorder resulting in severe encephalopathy, cortical atrophy, and cerebral hypomyelination.

Powered by WPeMatico